DRUG-INDUCED TOXIC EPIDERMAL NECROLYSIS: CLINICAL FEATURES AND THERAPY
Keywords:
drug allergy, toxic epidermal necrolysis, Lyell's syndrome, Stevens-Johnson syndrome, clinical caseAbstract
The article presents modern information about the causes, risk factors, course and methods of treatment of drug-induced toxic epidermal necrolysis. The above personal observation well illustrates the literature data regarding the etiology of the disease, the clinical picture and rational pharmacotherapy, including the features of local treatment.
References
1. Синдром Стивенса–Джонсона/Лайелла у взрослых: диагностика, маршрутизация, правила ведения/лечения, реабилитация: методические рекомендации / составители: Д.С. Фомина, Д.С. Проценко, Н.Ф. Плавунов [и др.]. – М.: ГБУЗ «ГКБ № 52 ДЗМ», 2022. – 71 с.
2. Seminario-Vidal L., Kroshinsky D., Malachowski S.J., Sun J., Markova A., Beac kofsky T.M., Kaffenberger B.H., Ergen E.N., Mauskar M., Bridges A., Calhoun C., Cardones A.R., Chen S.T., Chodosh J., Cotliar J., Davis M.D.P., DeNiro K.L., Dominguez A.R., Eljure-Téllez J., Femia A., Fox L.P., Guda A., Mitchell C., Mostaghimi A., OrtegaLoayza A.G., Owen C., Pasieka H., Rahnama-Moghadam S., Saeed H.N., Saunderson R.B., Shanbhag S., Sharon V.R., Strowd L., Venkatesh S., Wanat K.A., Wetter D.A., Worswick S., Micheletti R.G. Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults // J. Am. Acad. Dermatol. 2020 Jun; 82(6): 1553–1567. Doi: 10.1016/j.jaad.2020.02.066. Epub 2020 Mar 7. PMID: 32151629.
3. Shanbhag SS, Sangwan VS, Singh A, Donthineni PR, Basu S, Srinivasan B, Agarwal S, Iyer G. Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in India. Front Med (Lausanne). 2021 Aug 27;8:643955. doi: 10.3389/fmed.2021.643955. PMID: 34513854; PMCID: PMC8429498.
4. Weinkle A, Pettit C, Jani A, et al. Distinguishing Stevens - Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation—a retrospective chart review. J Am Acad Dermatol. 2019;81(3): 749-757.
5. Maity S, Banerjee I, Sinha R, Jha H, Ghosh P, Mustafi S. Nikolsky's sign: A pathognomic boon. J Family Med Prim Care. 2020 Feb 28;9(2):526-530. doi: 10.4103/jfmpc.jfmpc_889_19. PMID: 32318376; PMCID: PMC7114071.
6. Noe MH, Micheletti RG. Diagnosis and management of Stevens-Johnson syndrome/toxic epidermal necrolysis. Clin Dermatol. 2020 Nov-Dec;38(6):607-612. doi: 10.1016/j.clindermatol.2020.06.016. Epub 2020 Jun 30. PMID: 33341195.
7. Lee HY, Walsh SA, Creamer D. Long-term complications of Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who survive an episode of SJS/TEN necessitates multidisciplinary follow-up. Br J Dermatol. 2017;177(4):924-935.
8. Han F. et al. Successful treatment of toxic epidermal necrolysis using plasmapheresis: a prospective observational study //Journal of Critical Care. – 2017. – Т. 42. – С. 65-68.
9. Lerch M. et al. Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis //Clinical reviews in allergy & immunology. – 2018. – Т. 54. – С. 147-176.
10. Papp A. et al. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results //Burns. – 2018. – Т. 44. – №. 4. – С. 807-815.
Published
Issue
Section
License
Copyright (c) 2024 I.S. Razikova, N.P. Aidarova, V.F. Baibekova, B.T. Kudratillayeva (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All Rights Reserved.
